Skip to main navigation

Investors

Press Releases

Press Releases

All
2023
2022
2021
2020
2019
2018
2016

December 30, 2022

Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

December 10, 2022

Adicet Bio Reports Positive Data from Ongoing ADI-001 Phase 1 Trial in Patients with Relapsed or Refractory Aggressive B-Cell Non-Hodgkin’s Lymphoma (NHL)

December 2, 2022

Adicet Bio to Host Investor Webcast to Discuss Updated Clinical Data from Ongoing ADI-001 Phase 1 Trial in Patients with Relapsed or Refractory Aggressive B-Cell Non-Hodgkin’s Lymphoma (NHL)

November 30, 2022

Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

November 30, 2022

Adicet Bio to Present at the Virtual JMP Securities Hematology and Oncology Summit

November 29, 2022

Adicet Bio Appoints Nancy Boman, M.D., Ph.D., as Senior Vice President and Chief Regulatory Officer

November 8, 2022

Adicet Reports Third Quarter 2022 Financial Results and Provides Business Updates

November 7, 2022

Adicet Bio Showcases Preclinical Data for Four New Pipeline Programs at The Society for Immunotherapy of Cancer (SITC) 37th Annual Meeting

November 3, 2022

Adicet Bio Reports ASH Abstract Data from Ongoing ADI-001 Phase 1 Trial in Relapsed or Refractory Aggressive B-Cell Non-Hodgkin’s Lymphoma (NHL)

November 1, 2022

Adicet Bio to Present at the 2022 Jefferies London Healthcare Conference

Pagination

First page
Previous page
Page 1
Page 2
Current page 3
Page 4
Page 5
Page 6
Page 7
Page 8
Page 9
…
Next page
Last page

Displaying 21 - 30 of 110

Tools

Print

Print
Email Alerts

Email Alerts
Investor Contacts

Investor Contacts

IR Nav

Investors
Press Releases
Presentations & Events
Stock Information
Corporate Governance
Financial Information
Investor Resources

IR Nav

Investors
Press Releases
Presentations & Events
- Stock Quote & Chart
- Analyst Coverage
- Governance Highlights
- Leadership and Board of Directiors
Financial Information

Adicet - Header Navigation

About
Science
Pipeline
Investors
Careers
- Join Our Team
- Current Openings
Contact

IR Nav

Investors
Press Releases
Presentations & Events
Stock Information
- Stock Quote & Chart
- Analyst Coverage
Corporate Governance
- Governance Highlights
- Leadership and Board of Directiors
Financial Information
Investor Resources

© 2023 Adicet Bio All rights reserved. Website Design: Hane Chow, Inc.